Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes

Eradication of Mycobacterium tuberculosis (MTB) infection requires daily administration of combinations of rifampin (RIF), isoniazid [isonicotinylhydrazine (INH)], pyrazinamide, and ethambutol, among other drug therapies. To facilitate and optimize MTB therapeutic selections, a mononuclear phagocyte...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:FASEB J
Main Authors: Edagwa, Benson J., Guo, Dongwei, Puligujja, Pavan, Chen, Han, McMillan, JoEllyn, Liu, Xinming, Gendelman, Howard E., Narayanasamy, Prabagaran
Format: Artigo
Jezik:Inglês
Izdano: Federation of American Societies for Experimental Biology 2014
Teme:
Research Communications
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4232285/
https://ncbi.nlm.nih.gov/pubmed/25122556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.14-255786
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki